VAERS reports by lot

Moderna COVID-19 lot 061E21A: VAERS reports

268 VAERS reports list lot 061E21A as a Moderna COVID-19 vaccine, received between 2021-09-07 and 2024-01-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
268
Reports
10%
Marked serious
6
With a death outcome
21
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)19823%
Neurological13316%
Cardiac / Cardiovascular11313%
Injection-site / Local reaction9511%
Gastrointestinal769%
Dermatological (non-injection-site)648%
Respiratory637%
Musculoskeletal496%
Allergic / Anaphylactic293%
Psychiatric / Neuropsychiatric121%
Reproductive / Menstrual81%
Thrombotic / Hematological71%
Autoimmune / Immune-mediated61%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois51
California21
Florida15
New York12
Virginia12
Indiana12
Tennessee10
Pennsylvania10
Connecticut9
Texas9
Michigan9
South Carolina7

Reports by month received

2021-0934
2021-1083
2021-1137
2021-128
2022-0118
2022-023
2022-0356
2022-044
2022-052
2022-061
2022-071
2022-084
2022-102
2022-122
2023-014
2023-021
2023-032
2023-053
2023-061
2023-091
2024-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.